Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    72
    CASES:
    72
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
FDA808i-2
$255.00
Add To Collect

Description: Multiple organ cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA808h-2

Details: Multiple organ carcinoma tissue microarray with cancer adjacent normal tissue, containing 54 cases of multiple organ carcinoma, plus 18 cases of 6 types of cancer adjacent organs, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Normal(*)
  • NAT(*)
  • AT(*)
  • Malignant(*)
  • Malignant(0)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(III)
  • Malignant(IV)
  • _ph
TISSUE ARRAYS
FDA808i-2
1
2
3
4
5
6
7
8
9
A
Ute
Ute
Cer
Cer
Cer
Cer
Ske
Ske
Ske
B
Ski
Ski
Ski
Ner
Ner
Ner
Lun
Car
Car
C
Cer
Cer
Cer
Cer
Ova
Ova
Pan
Pan
Tes
D
Tes
Thy
Thy
Bre
Bre
Bre
Spl
Lun
Lun
E
Lun
Eso
Eso
Sto
Sma
Sma
Col
Col
Rec
F
Rec
Liv
Liv
Kid
Pro
Pro
Ute
Ute
Ute
G
Cer
Cer
Ske
Rec
Ski
Ski
Ner
Ret
Per
H
Lym
Lym
Lym
Lym
Bla
Bla
Car
Per
Smo
_ph
FDA808i-2
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 45 F Uterus Endometrium tissue * * * Normal
A2
2 18 F Uterus Endometrium tissue * * * Normal
A3
3 41 F Cervix Adjacent normal endometrium tissue * * * NAT
A4
4 36 F Cervix Cancer adjacent cervical canals tissue * * * AT
A5
5 72 F Cervix Adjacent normal cervix tissue * * * NAT
A6
6 65 F Cervix Adjacent normal cervix tissue * * * NAT
A7
7 40 M Skeletal muscle Skeletal muscle tissue * * * Normal
A8
8 49 F Skeletal muscle Adjacent normal skeletal muscle tissue * * * NAT
A9
9 50 M Skeletal muscle Skeletal muscle tissue * * * Normal
B1
10 45 M Skin Skin tissue * * * Normal
B2
11 37 M Skin Skin tissue * * * Normal
B3
12 18 F Skin Skin tissue * * * Normal
B4
13 35 M Nerve Peripheral nerve tissue * * * Normal
B5
14 25 M Nerve Peripheral nerve tissue * * * Normal
B6
15 40 M Nerve Peripheral nerve tissue * * * Normal
B7
16 21 F Lung Lung and pleura tissue * * * Normal
B8
17 26 F Cardiac pericardium Mesothelium tissue * * * Normal
B9
18 19 M Cardiac pericardium Pericardium and mesothelium tissue * * * Normal
C1
19 43 M Cerebrum Glioblastoma 4 * * Malignant
C2
20 65 F Cerebrum Atypical meningioma * * * Malignant
C3
21 61 F Cerebrum Glioblastoma 4 * * Malignant
C4
22 39 F Cerebrum Oligodendroglioma of right parietal lobe * * * Malignant
C5
23 63 F Ovary High grade serous carcinoma * T2N0M0 II Malignant
C6
24 29 F Ovary High grade serous carcinoma * T3N0M0 III Malignant
C7
25 16 F Pancreas Islet cell tumor * * * Malignant
C8
26 64 M Pancreas Duct adenocarcinoma 2 T3N0M0 IIA Malignant
C9
27 32 M Testis Seminoma * T1N0M0 I Malignant
D1
28 30 M Testis Embryonal carcinoma * T2N0M0 IB Malignant
D2
29 33 F Thyroid Medullary carcinoma * T3N0M0 I Malignant
D3
30 46 F Thyroid Papillary carcinoma * T4N0M0 IV Malignant
D4
31 67 F Breast Intraductal carcinoma with early infiltrate * TisN0M0 0 Malignant
D5
32 48 F Breast Invasive ductal carcinoma 2 T3N1M0 IIIA Malignant
D6
33 58 F Breast Invasive ductal carcinoma 2 T2N1M0 IIB Malignant
D7
34 21 M Spleen Diffuse B-cell lymphoma * * * Malignant
D8
35 61 M Lung Small cell undifferentiated carcinoma * T2N0M0 IB Malignant
D9
36 66 M Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant
E1
37 42 M Lung Adenocarcinoma 3 T1N0M0 IA Malignant
E2
38 68 M Esophagus Squamous cell carcinoma 2 T3N1M0 IIIA Malignant
E3
39 63 M Esophagus Adenocarcinoma 3 T3N0M0 IIA Malignant
E4
40 73 F Stomach Mucinous adenocarcinoma 3 T2N1M0 IIA Malignant
E5
41 64 F Small intestine Adenocarcinoma with necrosis (sparse) 3 T4N0M0 IIB Malignant
E6
42 71 F Small intestine Malignant interstitialoma * T2N0M0 I Malignant
E7
43 72 F Colon Adenocarcinoma 1 T4N0M0 IIB Malignant
E8
44 54 M Colon Interstitialoma * T2N0M0 I Malignant
E9
45 36 M Rectum Adenocarcinoma 2 T2N0M0 I Malignant
F1
46 63 F Rectum Malignant interstitialoma * T2N0M0 I Malignant
F2
47 55 F Liver Hepatocellular carcinoma 2 T3N0M0 III Malignant
F3
48 17 F Liver Hepatoblastoma * * * Malignant
F4
49 60 M Kidney Clear cell carcinoma 1 T2N0M0 II Malignant
F5
50 80 M Prostate Adenocarcinoma (Gleason grade:4, gleason score:4+4) * T2N1M1C IV Malignant
F6
51 77 M Prostate Adenocarcinoma (Gleason grade:5, gleason score:5+4) * T2N0M0 IIA Malignant
F7
52 56 F Uterus Lowly malignant leiomyosarcoma * T2BN0M0 IIB Malignant
F8
53 50 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
F9
54 57 F Uterus Clear cell carcinoma * T1CN0M0 IC Malignant
G1
55 36 F Cervix Squamous cell carcinoma 3 T1BN0M0 IB Malignant
G2
56 49 F Cervix Invasive squamous cell carcinoma 3 T2N0M0 II Malignant
G3
57 20 F Skeletal muscle Embryonal rhabdomyosarcom of left leg * T1AN0M0 IA Malignant
G4
58 70 F Rectum Malignant melanoma * T4N0M0 IIB Malignant
G5
59 61 M Skin Basal cell carcinoma of left face * T2N0M0 IIA Malignant
G6
60 64 M Skin Squamous cell carcinoma with necrosis of chest wall 2 T3N0M0 IIA Malignant
G7
61 21 M Nerve Neurofibroma of back * * * Malignant
G8
62 1 F Retroperitoneum Neuroblastoma * * * Malignant
G9
63 60 M Peritoneum Malignant mesothelioma * T2N0M0 II Malignant
H1
64 55 M Lymph node Diffuse B cell lymphoma of armpit * * * Malignant
H2
65 50 F Lymph node Diffuse B cell lymphoma of right thigh * * * Malignant
H3
66 27 M Lymph node Hodgkin's lymphoma of left groin (mixed cell type) * * * Malignant
H4
67 36 M Lymph node Anaplastic large cell lymphoma of left groin * * * Malignant
H5
68 58 F Bladder High grade urothelial carcinoma * T2N0M0 II Malignant
H6
69 62 M Bladder Lowly malignant leiomyosarcoma * T2N0M0 II Malignant
H7
70 51 M Cartilage Well differentiated osteosarcoma of left femur * T2N0M0 II Malignant
H8
71 48 F Peritoneum Highly malignant pleomorphic rhabdomyosarcoma * T2N0M0 II Malignant
H9
72 60 F Smooth muscle Moderate malignant leiomyosarcoma of left buttock * T2BN0M0 IIB Malignant
_pheochromocytoma_
Find overlapping cases with this tissue array:
  • FDA808i-2
    File Format: .xlsx
    Release Date: 2025-01-17 15:57:38
    Download
1.570248s